The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sivertseva S.A.

Tyumen Regional Center for Multiple Sclerosis, Medical unit «Neftyanik»;
Ural State Medical University;
Kirov State Medical University

Latsh N.Yu.

Pirogov National Research Medical University

Zotova A.V.

Tyumen Regional Center for Multiple Sclerosis — AO MSCH «Neftyanik»

Sivertseva A.M.

Sechenov First Moscow State Medical University

Titkova E.R.

Sechenov First Moscow State Medical University

Boyko A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

A role of cerebrovascular diseases in the progression of multiple sclerosis

Authors:

Sivertseva S.A., Latsh N.Yu., Zotova A.V., Sivertseva A.M., Titkova E.R., Boyko A.N.

More about the authors

Read: 1439 times


To cite this article:

Sivertseva SA, Latsh NYu, Zotova AV, Sivertseva AM, Titkova ER, Boyko AN. A role of cerebrovascular diseases in the progression of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(5):53‑57. (In Russ.)
https://doi.org/10.17116/jnevro202412405153

Recommended articles:
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Functional state of the kidneys in patients with various types of cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):105-111
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107

References:

  1. Boyko AN, Bykova OV, Sivertseva SA. Rasseyannyy skleroz u detey i podrostkov: klinika, diagnostika, lechenie. M.: OOO «Izdatelʹstvo «Meditsinskoe informatsionnoe agentstvo»; 2016. (In Russ.).
  2. Sivertseva SA, Prilenskaya AM, Bazhukhin DV, et al. The risk of ischemic strokes in patients with multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. Spetsvypuski. 2018;118(8-2):88-94. (In Russ.). https://doi.org/10.17116/jnevro201811808288
  3. LeVine StM. Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered? Frontiers of Neurology. 2016;7:128.  https://doi.org/10.3389/fneur.2016.00128
  4. D’haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. The Lancet Neurology. 2011;10(7):657-666.  https://doi.org/10.1016/S1474-4422(11)70105-3
  5. Marrie RA, Fisk JD, Fitzgerald K, et al. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances. Front Immunol. 2023;14:1197195. https://doi.org/10.3389/fimmu.2023.1197195
  6. Thormann A, Sørensen PS, Koch-Henriksen N, et al. Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality. Neurology. 2017;89(16):1668-1675. https://doi.org/10.1212/WNL.0000000000004508
  7. Christiansen CF. Risk of vascular disease in patients with multiple sclerosis: a review. Neurological Research. 2012;34(8):746-753.  https://doi.org/10.1179/1743132812Y.0000000051
  8. Palladino R, Marrie RA, Majeed A, Chataway J. Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England. JAMA Neurol. 2020;77(7):820-828.  https://doi.org/10.1001/jamaneurol.2020.0664
  9. Hong Y, Tang HR, Ma M, et al. Multiple sclerosis and stroke: a systematic review and meta-analysis. BMC Neurology. 2019;19:139.  https://doi.org/10.1186/s12883-019-1366-7
  10. Belliston SM, Dubinsky RM, Lynch SG. Cerebrovascular Comorbidities in Multiple Sclerosis: Analysis of the Nationwide Inpatient Sample. Neurol Disord Stroke Int. 2018;1(2):1012.
  11. Geraldes R, Esiri M, DeLuca GC, Palace J. Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis. Brain Pathol. 2017;27(6):707-722.  https://doi.org/10.1111/bpa.12460
  12. Salah NM, Elsadek AM, ELnabil LM, et al. Assessment of cerebral hemodynamics in multiple sclerosis patients. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021;57:37.  https://doi.org/10.1186/s41983-021-00291-7
  13. Zulfiqar M, Qeadan F, Ikram A, et al. Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study J Stroke Cerebrovasc Dis. 2019;28(2):267-275.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.050

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.